Holborn Wells and SpeedBio India forms JV to manufacture in vitro diagnostics
Both parties are expected to invest a total of US $ 1 million to establish the brand
Both parties are expected to invest a total of US $ 1 million to establish the brand
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Filing marks first protein-based vaccine submitted to MHRA for authorization
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Since its inception, the company has either acquired or taken a majority stake in five companies
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
Subscribe To Our Newsletter & Stay Updated